Evaluation of the Impact of the use of Eltrombopag in a Real-Life Setting in France Based on Data in the National Observatory for Medullar Insufficiency
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- Acronyms The Revepi Study
- 08 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association